Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1989;36(6):551-4.
doi: 10.1007/BF00637734.

Relevance of genetic polymorphism in drug metabolism in the development of new drugs

L P Balant  1 , U Gundert-Remy, A R Boobis, C von Bahr
Affiliations
Clinical Trial

Relevance of genetic polymorphism in drug metabolism in the development of new drugs

L P Balant et al. Eur J Clin Pharmacol. 1989.

Abstract

Drugs whose principal metabolic pathways are under polymorphic genetic regulation may show considerable interindividual pharmacokinetic variability. This could lead to clinically significant differences in the pharmacological responses of some patients and so might lead the pharmaceutical industry to stop development of the drug. This can be prevented and there are several measures that can be taken to avoid such premature termination of development. They include studies in vitro with human liver samples, and clinical pharmacological experiments designed specifically to examine possible genetic polymorphism in the disposition of the drug.

PubMed Disclaimer

References

    1. Clin Pharmacokinet. 1986 Jan-Feb;11(1):1-17 - PubMed
    1. Clin Pharmacokinet. 1982 Jan-Feb;7(1):1-22 - PubMed
    1. Gastroenterology. 1983 Sep;85(3):682-92 - PubMed
    1. Clin Pharmacol Ther. 1985 Nov;38(5):481-7 - PubMed
    1. Eur J Clin Pharmacol. 1985;28(3):317-20 - PubMed

Publication types

Substances

LinkOut - more resources